Friday, 20 December 2013

AstraZeneca: Per Ardua ad Astra?

Hello there,

Today's idea is a single stock idea in the Healthcare space, the UK-based pharmaceutical giant AstraZeneca. 


Recent years have seen Astra experience more than its fair share of problems (loss of patents for key drugs, difficulty in developing new drugs), but now there are several signs that finally matters may be improving for the company.,


Please click on the web link below to read the full story...



As always, I am interested in any comments you may have, so please don't hesitate!

Happy reading and bon weekend,

Edmund

1 comment:

  1. Epic Research has a brilliant team for market recommendation, traders can join our services with nominal trading charges.

    ReplyDelete